March2 Alleviates Aortic Aneurysm/Dissection by Regulating PKM2 Polymerization
Circulation Research · 11.04.2025 · 136 (8)
DOI: 10.1161/circresaha.124.325049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, erschienen am 11.04.2025. Verfasst von Yiran E Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Institute of Cardiovascular Diseases (Y.E.L., S.L., Litao Wang, Y.D., L. Wu, H.C., T.Z., J.L., S.X., L.L., J.G., J…. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Membrane Proteins, Aortic Dissection, Thyroid Hormones. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 72 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Aortic aneurysm/dissection (AAD) is a life-threatening disease lacking effective pharmacological treatment. Protein ubiquitination plays a pivotal role in cardiovascular diseases. However, the possible contribution of the E3 ubiquitin ligase March2 (membrane-associated RING [really interesting new gene] finger protein 2) to the cause of AAD remains elusive. METHODS: Integrated single-cell RNA sequencing analysis was conducted in human AAD tissues. Based on the screening results, we generated a mouse line of smooth muscle cell–specific March2 knockout. β-Aminopropionitrile monofumarate was used to establish AAD. Cleavage under targets and tagmentation and cleavage under targets and tagmentation–quantitative polymerase chain reaction were performed to identify possible target genes for histone H3K18 lactylation. RESULTS: March2 expression was downregulated in aorta from patients with AAD or β-aminopropionitrile monofumarate–induced AAD mice. β-Aminopropionitrile monofumarate–induced AAD was significantly accentuated in March2 global (March2 –/– ) and vascular smooth muscle cell–specific deletion (March2 fl/fl ; Tagln Cre ) mice, whereas the AAD pathology was rescued by rAAV9-SM22α (smooth muscle 22α)-March2 (recombinant adeno-associated virus serotype 9 expressing Flag-tagged March2 under SM22α promoter). March2 interacted with PKM2 (pyruvate kinase M2) to promote K33-linked polyubiquitination. Deficiency of March2 lessened PKM2 dimer-to-tetramer conversion in AAD and overtly exacerbated AAD-induced histone H3K18 lactylation in vascular smooth muscle cells by fostering glucose metabolism reprogramming, thereby promoting p53-driven apoptotic transcriptional response—a hallmark of AAD pathogenesis. TEPP-46 (tetraethyl pyrophosphate), a PKM2-specific activator, pronouncedly alleviated March2 deficiency–deteriorated AAD pathology. CONCLUSIONS: Our findings demonstrated that March2 is a novel endogenous defender that prevents AAD by inhibiting vascular smooth muscle cell apoptosis, suggesting that March2 represents a potential therapeutic target for AAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Shanghai Institute of Cardiovascular Diseases (Y.E.L., S.L., Litao Wang, Y.D., L. Wu, H.C., T.Z., J.L., S.X., L.L., J.G., J.R., Y.Z.), Zhongshan Hospital, Fudan University, China.
- State Key Laboratory of Cardiovascular Diseases (Y.E.L., S.L., Litao Wang, Y.D., L. Wu, H.C., T.Z., J.L., S.X., L.L., Z.L., Lixin Wang, J.G., J.R., Y.Z.), Zhongshan Hospital, Fudan University, China.
- National Health Commission (NHC) Key Laboratory of Ischemic Heart Diseases, Shanghai, China (Y.E.L., S.L., Litao Wang, Y.D., L. Wu, H.C., T.Z., J.L., S.X., L.L., J.G., J.R., Y.Z.).
- National Clinical Research Center for Interventional Medicine, Shanghai, China (Y.E.L., S.L., Litao Wang, Y.D., L. Wu, H.C., T.Z., J.L., S.X., L.L., J.G., J.R., Y.Z.).
- Key Laboratory of Viral Heart Diseases, National Health Commission, Shanghai, China (Y.E.L., S.L., Litao Wang, Y.D., L. Wu, H.C., T.Z., J.L., S.X., L.L., J.G., J.R., Y.Z.).
- Department of Vascular Surgery (Z.L., Lixin Wang), Zhongshan Hospital, Fudan University, China.
ORCID-Profile: Litao Wang, Jie Lin, Shengjun Xiong, Yayu Wang, Qijun Zheng, Rongjun Zou, Ling Lin, Lixin Wang, Jun Ren, Yingmei Zhang
Zitieren
APA
Li, Y. E., Liu, S., Wang, L., Du, Y., Wu, L., Chen, H., Zhu, T., Lin, J., Xiong, S., Wang, Y., Zheng, Q., Zou, R., Lin, L., Li, Z., Wang, L., Ge, J., Ren, J., & Zhang, Y. (2025). March2 Alleviates Aortic Aneurysm/Dissection by Regulating PKM2 Polymerization. Circulation Research, 136(8). https://doi.org/10.1161/circresaha.124.325049
Vancouver
Li YE, Liu S, Wang L, Du Y, Wu L, Chen H, et al. March2 Alleviates Aortic Aneurysm/Dissection by Regulating PKM2 Polymerization. Circulation Research. 2025;136(8). doi:10.1161/circresaha.124.325049
BibTeX
@article{Li2025,
author = {Li, Yiran E and Liu, Shuolin and Wang, Litao and Du, Yuxin and Wu, Lin and Chen, Haoran and Zhu, Tingfang and Lin, Jie and Xiong, Shengjun and Wang, Yayu and Zheng, Qijun and Zou, Rongjun and Lin, Ling and Li, Zheyun and Wang, Lixin and Ge, Junbo and Ren, Jun and Zhang, Yingmei},
title = {March2 Alleviates Aortic Aneurysm/Dissection by Regulating PKM2 Polymerization},
journal = {Circulation Research},
year = {2025},
volume = {136},
number = {8},
doi = {10.1161/circresaha.124.325049}
}
EUVIMED